Illumina DRAGEN GCP Lvl 4 1-year License
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Place of performance: North Bethesda, MD
Don't lose track of this one
We'll email you once about this listing. No list, no cadence.
Free. Verify your email, then we send one reminder only.
- Posted
- Sep 3, 2026
- Closes
- No deadline published by the funder
Similar opportunities open now
- Illumina DRAGEN Tier 3 Throughput License and v4 ServerSame funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
- Multiomic profiling of cardiometabolic diseases (Illumina)Same funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
- CLC Genomics Workbench Software Maintenance and License RenewalSame funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
- high-throughput proteomics platform that uses proximity extension and LicenseOpenDEPT OF DEFENSENo deadline listed
- Comprehensive full-service maintenance/repair plan for Illumina Nova/Seq 6000OpenDEPT OF DEFENSECloses Dec 2026
At a glance
This is a government contract opportunity posted by HEALTH AND HUMAN SERVICES, DEPARTMENT OF in the research and development in biotechnology (except nanobiotechnology) category. Work is performed in North Bethesda, MD.
Classification and identifiers
- Industry (NAICS)
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- Product or service (PSC)
- Business Application Off-The-Shelf Software Delivered By Perpetual License, Which Also Encompasses Enterprise Level Software Enabling Mission Capability and Business Operational Support. (7A21)
- Solicitation number
- 75N98026Q01035
- Contracting office
- NATIONAL INSTITUTES OF HEALTH OLAO
Who can apply
About this opportunity
The National Institute of Neurological Disorders and Stroke (NINDS), Neurodegenerative Diseases Research Section (NDRS), requires a 12-month subscription/access to the Illumina DRAGEN GCP Level 4 platform to process approximately 1,300,000 GB of whole-genome sequencing data derived from 10,000 human genomes. The platform must support graph-based alignment to the human reference genome (hg38), accurate variant calling, and detection of single-nucleotide variants, insertions/deletions, structural variants, copy number variants, and repeat expansions. The platform must be fully compatible with Illumina-generated sequencing data and existing DRAGEN-processed datasets. The contractor shall provide access and operational availability of the DRAGEN GCP platform and processing capability sufficien...